Sept 15 (Reuters) - Merck & Co Inc MRK.N :
* BRENZYS® (ETANERCEPT INJECTION) NOW INDICATED FOR THE TREATMENT OF PLAQUE PSORIASIS, PSORIATIC ARTHRITIS AND JUVENILE IDIOPATHIC ARTHRITIS
* MERCK & CO INC - HEALTH CANADA HAS APPROVED BRENZYS , A TNF-INHIBITOR, FOR FOUR NEW INDICATIONS